Main Article Content
Aim: The present study aims to demonstrate the incidence of Candida species associated with infections in a Military hospital in Alkharj.
Methodology: This is a retrospective study that was conducted to assess the prevalence of Candida species in a Military hospital in Alkharj – Saudi Arabia. The isolates from various clinical specimens in 2018 and 2019 were studied.
Results: The percentage of candida species in the 2 years was 6.21% of isolates. The Candida albicans were 40.87% of the total Candida isolates. The majority of Candida species cultures were collected from wound/pus/skin or vagina and to lesser extent urine and lower respiratory tract.
Conclusion: Candida species are now common pathogens that cause infections specially in the gastrointestinal tract, vagina and at surgical site. It sometimes may lead to high morbidity and mortality rate. It is important to know the resistance rate for the fungi and it is important to start the implementation of antifungal treatment programs.
Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: A propensity analysis. Clin Infect Dis. 2005;41(9):1232-9.
Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309-17.
Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RJ et al. International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J ClinMicrobiol. 2001;39(9):3254-9.
Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J. Epidemiology of candidemia in Swiss tertiary care hospitals: Secular trends, 1991–2000. Clin Infect Dis. 2004;38(3):311-20.
Almooosa Z, Ahmed GY, Omran A, AlSarheed A, Alturki A, Alaqeel A. Invasive candidiasis in pediatric patients at King Fahad Medical City in Central Saudi Arabia. A 5-year retrospective study. Saudi Med J. 2017;38(11):1118-1124.
Cohen R, Roth FJ, Delgado E, Ahearn DG, Kalser MH. Fungal flora of the normal human small and large intestine. N Engl J Med. 1969;280(12):638-41.
Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia. The attributable mortality and excess of stay. Arch Intern Med. 1988;148:2642-5.
Wenzel RP. Nosocomial candidemia: Risk factors and attributable mortality. Clin Infect Dis. 1995;20:1531-4.
Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, Messer S et al. Attributable mortality of nosocomial candidemia. Clin Infect Dis. 2003;37:1172-7.
Lockhart SR. Current epidemiology of Candida Infection. Clin. Microbiol. Newsl. 2014;36(17):131–136 •
Yapar N. Epidemiology and risk factors for invasive candidiasis. TherClin Risk Manag. 2014;10:95-105.
Tortorano AM, Peman J, Bernhardt H, Klingspor L, Kibbler CC, Faure O et al. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J ClinMicrobiol Infect Dis. 2004;23(4): 317-22.
Pfaller MA, Messer SA, Hollis RJ, Jones RN, Doern GV, Brandt ME et al. Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. Diagn. Microbiol. Infect. Dis.1999;33:121-129.
Al-Tawfiq JA. Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996–2004. Int J Infect Dis. 200;11(3):239-44.
Bukharie HA. Nosocomial candidemia in a tertiary care hospital in Saudi Arabia. Mycopathologia. 2002;153(4):195–198.
Akbar DH, Tahawi AT. Candidemia at a University Hospital: Epidemiology, risk factors and predictors of mortality. Ann. Saudi Med. 2001;21(3-4):178– 182.
Al-Hedaithy SS. The yeast species causing fungemia at a university hospital in Riyadh, Saudi Arabia, during a 10-year period. Mycoses. 2003;46(8):293–298.
Al Thaqafi AHO, Farahat FM, Al Harbi MI, Al Amri AFW, Perfect JR. Predictors and outcomes of Candida bloodstream infection: Eight-year surveillance, western Saudi Arabia. International Journal of Infectious Diseases. 2014;21:5–9.
Omrani AS, Makkawy EA, Baig K, Baredhwan AA, Almuthree SA, Elkhizzi NA et al. Ten-year review of invasive Candida infections in a tertiary care center in Saudi Arabia. Saudi Med J. 2014;35(8): 821-6.
Bouza E, Muñoz P. Epidemiology of candidemia in intensive care units. Int J Antimicrob Agents. 2008;32(Suppl 2):S87-91.
Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immuno suppressed patients. Lancet Infect Dis. 2003;3(11):685-702.
Ostrosky-Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Crit Care Med. 2006;34(3):857-63.
Al-Dorzi HM, Sakkijha H, Khan R, Aldabbagh T, Toledo A, Ntinika P et al. Invasive candidiasis in critically ill patients: A prospective cohort study in two tertiary care centers. J Intensive Care Med. 2018;885066618767835.
Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med. 2002;113(6):480-5.
Sheevani, Sharma P, Aggarwal A. Nosocomial Candida infection in a rural tertiary care hospital. J ClinDiagn Res. 2013;7:405–6.
Ahmed NJ, Khan MF. Antibiotic Resistance Patterns in a University Hospital in Al-Kharj City. Antibiotic Resistance Patterns in a University Hospital in Al-Kharj City. J. Pharm. Res. Int. 2019;31(5):1-5.
Bac ND, Anh LT, Quang LB, Luc NK, Nga TTT, Nagi M et al. Prevalence of Candida bloodstream isolates from patients in two hospitals in Vietnam.Iran J Microbiol. 2019;11(2):108-113.
Pfaller MA, Diekema DJ. Epidemiology of Invasive Candidiasis: A Persistent Public Health Problem. ClinMicrobiol Rev. 2007; 20(1):133-63.
DermNet NZ. Vulvovaginal candidiasis; 2020.
[cited 31 March 2020].
Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369(9577):1961-71.
Benedict K, Jackson BR, Chiller T, Beer KD. Estimation of direct healthcare costs of fungal diseases in the United States. Clin Infect Dis. 2019;68(11):1791-1797.
ASHP. Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery; 2020.
[cited 31 March 2020].
CDC. Candidiasis; 2020.
[cited 31 March 2020]
Pendleton KM, Huffnagle GB, Dickson RP. The significance of Candida in the human respiratory tract: our evolving understanding. Pathog Dis. 2017;75(3).
Fisher JF, Chew WH, Shadomy S, Duma RJ, Mayhall CG, House WC. Urinary tract infections due to Candida albicans. Rev Infect Dis. 1982;4(6):1107-18.
Carol A. Kauffman. Diagnosis and Management of Fungal Urinary Tract Infection. Infect Dis Clin North Am. 2014; 28(1):61-74.